 John Repine
Concepts (726)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 118 | 2005 | 1089 | 4.700 |
Why?
| | Interleukin-1 | 32 | 2015 | 965 | 2.940 |
Why?
| | Xanthine Oxidase | 42 | 2003 | 71 | 2.790 |
Why?
| | Oxygen | 54 | 2016 | 851 | 2.780 |
Why?
| | Lung | 91 | 2013 | 3521 | 2.720 |
Why?
| | Hydrogen Peroxide | 48 | 2000 | 288 | 2.230 |
Why?
| | Rats | 100 | 2015 | 4913 | 1.570 |
Why?
| | Oxidative Stress | 12 | 2016 | 1068 | 1.460 |
Why?
| | Catalase | 41 | 1997 | 118 | 1.390 |
Why?
| | Antioxidants | 13 | 2012 | 529 | 1.260 |
Why?
| | Superoxides | 28 | 1999 | 190 | 1.210 |
Why?
| | Pulmonary Edema | 23 | 1997 | 109 | 1.120 |
Why?
| | Thiourea | 29 | 1995 | 39 | 1.120 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 348 | 1.100 |
Why?
| | Rats, Sprague-Dawley | 37 | 2015 | 2182 | 1.080 |
Why?
| | Animals | 171 | 2016 | 31565 | 1.000 |
Why?
| | Bronchoalveolar Lavage Fluid | 14 | 2016 | 580 | 0.970 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 127 | 0.940 |
Why?
| | Endothelium, Vascular | 15 | 2002 | 830 | 0.900 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 25 | 0.860 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.800 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 813 | 0.770 |
Why?
| | Ferritins | 4 | 2004 | 52 | 0.750 |
Why?
| | Blood Bactericidal Activity | 20 | 1992 | 35 | 0.720 |
Why?
| | Glutathione | 19 | 2000 | 293 | 0.700 |
Why?
| | Interferon Type I | 1 | 2021 | 128 | 0.700 |
Why?
| | Reperfusion Injury | 15 | 1997 | 252 | 0.680 |
Why?
| | In Vitro Techniques | 45 | 1996 | 1003 | 0.670 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 743 | 0.670 |
Why?
| | Prostaglandins | 3 | 2019 | 77 | 0.670 |
Why?
| | Ischemia | 11 | 1997 | 361 | 0.660 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 10 | 0.650 |
Why?
| | Chemokines, CXC | 6 | 2005 | 60 | 0.650 |
Why?
| | Leukotrienes | 1 | 2019 | 33 | 0.640 |
Why?
| | Free Radicals | 24 | 2008 | 99 | 0.640 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 372 | 0.630 |
Why?
| | Virus Diseases | 1 | 2021 | 195 | 0.630 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 179 | 0.630 |
Why?
| | Aerosols | 4 | 2016 | 150 | 0.620 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 42 | 0.620 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 907 | 0.610 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 305 | 0.610 |
Why?
| | Lung Injury | 9 | 2014 | 192 | 0.600 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 350 | 0.580 |
Why?
| | Cytokines | 8 | 2014 | 1824 | 0.580 |
Why?
| | Capillary Permeability | 13 | 1998 | 137 | 0.580 |
Why?
| | Chemotactic Factors | 11 | 1997 | 50 | 0.580 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 360 | 0.580 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 347 | 0.570 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 319 | 0.570 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 385 | 0.550 |
Why?
| | Oxidants | 6 | 2004 | 112 | 0.550 |
Why?
| | Malathion | 1 | 2016 | 1 | 0.530 |
Why?
| | Chemotaxis, Leukocyte | 9 | 1997 | 128 | 0.530 |
Why?
| | Pneumonia | 5 | 2011 | 563 | 0.520 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 151 | 0.510 |
Why?
| | Capillaries | 2 | 2015 | 90 | 0.510 |
Why?
| | Macrophages | 24 | 1991 | 1259 | 0.510 |
Why?
| | Kidney | 11 | 1999 | 1182 | 0.500 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 71 | 0.500 |
Why?
| | Respiration, Artificial | 3 | 2015 | 528 | 0.490 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 51 | 0.490 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 53 | 0.490 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 95 | 0.490 |
Why?
| | Glutamine | 1 | 2015 | 91 | 0.480 |
Why?
| | Lung Diseases | 10 | 2007 | 690 | 0.460 |
Why?
| | Male | 101 | 2019 | 55396 | 0.460 |
Why?
| | Phagocytosis | 22 | 2007 | 349 | 0.450 |
Why?
| | Hemorrhage | 4 | 2004 | 600 | 0.450 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 269 | 0.450 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 21 | 0.440 |
Why?
| | Quinacrine | 3 | 2004 | 7 | 0.440 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 94 | 0.430 |
Why?
| | Nitric Oxide | 8 | 2014 | 817 | 0.430 |
Why?
| | Hydroxides | 9 | 1991 | 25 | 0.430 |
Why?
| | Antigens, CD | 1 | 2015 | 440 | 0.420 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 107 | 0.410 |
Why?
| | Myocardium | 14 | 1992 | 911 | 0.400 |
Why?
| | Allopurinol | 11 | 2003 | 53 | 0.400 |
Why?
| | Inflammation | 6 | 2016 | 2464 | 0.400 |
Why?
| | Perfusion | 21 | 1998 | 147 | 0.400 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1024 | 0.400 |
Why?
| | Peroxidase | 14 | 2003 | 161 | 0.390 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 34 | 0.380 |
Why?
| | Cell Adhesion | 15 | 2007 | 426 | 0.380 |
Why?
| | Fruit | 1 | 2012 | 119 | 0.380 |
Why?
| | Burns | 4 | 2019 | 237 | 0.370 |
Why?
| | Vegetables | 1 | 2012 | 133 | 0.370 |
Why?
| | Humans | 124 | 2021 | 114043 | 0.370 |
Why?
| | Rabbits | 29 | 1991 | 733 | 0.370 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 29 | 0.370 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1128 | 0.360 |
Why?
| | Cells, Cultured | 28 | 2008 | 3861 | 0.360 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 55 | 0.360 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 523 | 0.360 |
Why?
| | Tungsten | 15 | 2003 | 27 | 0.350 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 407 | 0.350 |
Why?
| | Pentoxifylline | 4 | 1997 | 21 | 0.350 |
Why?
| | Erythrocytes | 11 | 1995 | 568 | 0.350 |
Why?
| | Cattle | 18 | 2007 | 918 | 0.340 |
Why?
| | Heart | 10 | 1994 | 613 | 0.330 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 917 | 0.330 |
Why?
| | Biomarkers | 9 | 2019 | 3397 | 0.330 |
Why?
| | Soot | 1 | 2008 | 16 | 0.310 |
Why?
| | Vitamin E | 4 | 1998 | 110 | 0.310 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 204 | 0.310 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.310 |
Why?
| | Dietary Supplements | 1 | 2012 | 459 | 0.310 |
Why?
| | Oxygen Consumption | 19 | 1995 | 587 | 0.300 |
Why?
| | Gulf War | 2 | 2019 | 9 | 0.300 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 59 | 0.290 |
Why?
| | Dinoprost | 2 | 2019 | 31 | 0.290 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 228 | 0.290 |
Why?
| | Platelet Activating Factor | 3 | 2000 | 69 | 0.280 |
Why?
| | Bacterial Infections | 7 | 1993 | 217 | 0.280 |
Why?
| | Tyrosine | 2 | 2008 | 210 | 0.280 |
Why?
| | Particulate Matter | 1 | 2008 | 185 | 0.280 |
Why?
| | Blood Platelets | 7 | 1992 | 326 | 0.270 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 147 | 0.270 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 8 | 0.270 |
Why?
| | Shock, Septic | 3 | 2000 | 185 | 0.270 |
Why?
| | Leukocytes | 7 | 2007 | 272 | 0.260 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 78 | 0.260 |
Why?
| | Trachea | 6 | 2005 | 223 | 0.260 |
Why?
| | Endothelium | 10 | 1997 | 109 | 0.260 |
Why?
| | Phagocytes | 2 | 2003 | 90 | 0.260 |
Why?
| | Obesity | 2 | 2015 | 2505 | 0.250 |
Why?
| | Muscles | 3 | 1991 | 320 | 0.250 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1228 | 0.250 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 25 | 0.240 |
Why?
| | Administration, Inhalation | 5 | 2016 | 637 | 0.240 |
Why?
| | Leukotriene B4 | 3 | 2016 | 42 | 0.240 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.240 |
Why?
| | Mitochondria | 5 | 2008 | 744 | 0.240 |
Why?
| | Endotoxins | 7 | 1992 | 211 | 0.240 |
Why?
| | Postoperative Complications | 1 | 2015 | 2122 | 0.240 |
Why?
| | Tidal Volume | 2 | 2015 | 75 | 0.230 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 637 | 0.230 |
Why?
| | Coronary Disease | 5 | 1991 | 348 | 0.230 |
Why?
| | Skin | 3 | 1995 | 653 | 0.230 |
Why?
| | Growth Substances | 4 | 1997 | 138 | 0.220 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 40 | 0.220 |
Why?
| | Leukocyte Count | 8 | 2003 | 292 | 0.220 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 10 | 0.220 |
Why?
| | Environmental Exposure | 2 | 2017 | 372 | 0.220 |
Why?
| | Smoking | 7 | 2014 | 1382 | 0.210 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 53 | 0.210 |
Why?
| | Organ Size | 10 | 1998 | 434 | 0.200 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 1836 | 0.200 |
Why?
| | Risk Factors | 9 | 2019 | 8614 | 0.200 |
Why?
| | Particle Size | 3 | 2016 | 317 | 0.200 |
Why?
| | Edema | 4 | 1997 | 119 | 0.190 |
Why?
| | Neutropenia | 5 | 1997 | 123 | 0.190 |
Why?
| | von Willebrand Factor | 3 | 2019 | 55 | 0.190 |
Why?
| | Thromboxanes | 4 | 1988 | 14 | 0.190 |
Why?
| | Glycine | 1 | 2002 | 152 | 0.190 |
Why?
| | Corneal Stroma | 1 | 2001 | 15 | 0.190 |
Why?
| | Administration, Intranasal | 1 | 2021 | 75 | 0.180 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 13 | 0.180 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 27 | 0.180 |
Why?
| | Sodium | 2 | 1999 | 184 | 0.180 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 445 | 0.180 |
Why?
| | Renal Circulation | 4 | 1997 | 53 | 0.180 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 27 | 0.180 |
Why?
| | Nitrates | 2 | 2017 | 71 | 0.170 |
Why?
| | Female | 32 | 2019 | 59325 | 0.170 |
Why?
| | Acute Disease | 8 | 1999 | 907 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 476 | 0.170 |
Why?
| | Indicators and Reagents | 6 | 2000 | 99 | 0.170 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 12 | 0.170 |
Why?
| | Iron | 7 | 1997 | 232 | 0.170 |
Why?
| | Kinetics | 12 | 1996 | 1547 | 0.170 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 158 | 0.160 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 67 | 0.160 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 15 | 0.160 |
Why?
| | Lactoferrin | 2 | 2017 | 27 | 0.160 |
Why?
| | Physical Exertion | 1 | 2000 | 209 | 0.160 |
Why?
| | Cell Count | 3 | 2013 | 303 | 0.160 |
Why?
| | Sulfonamides | 1 | 2002 | 444 | 0.160 |
Why?
| | Luminescent Measurements | 8 | 1997 | 74 | 0.160 |
Why?
| | Interleukin-8 | 3 | 1997 | 229 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 186 | 0.150 |
Why?
| | Multiple Trauma | 1 | 1999 | 87 | 0.150 |
Why?
| | Monocytes | 7 | 2007 | 503 | 0.150 |
Why?
| | Permeability | 6 | 2000 | 149 | 0.150 |
Why?
| | Brain Edema | 2 | 1990 | 59 | 0.150 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 113 | 0.150 |
Why?
| | Alprostadil | 2 | 1997 | 31 | 0.150 |
Why?
| | Molybdenum | 1 | 1997 | 8 | 0.150 |
Why?
| | Acetylcysteine | 3 | 1995 | 141 | 0.140 |
Why?
| | Intubation, Intratracheal | 5 | 2000 | 214 | 0.140 |
Why?
| | Veterans Health | 1 | 2019 | 166 | 0.140 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 40 | 0.140 |
Why?
| | Chronic Disease | 3 | 2014 | 1577 | 0.140 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 561 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 474 | 0.140 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 65 | 0.140 |
Why?
| | Phospholipases A | 1 | 1997 | 95 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 1997 | 78 | 0.140 |
Why?
| | Sepsis | 2 | 2000 | 507 | 0.140 |
Why?
| | DNA Damage | 1 | 1999 | 351 | 0.130 |
Why?
| | Hypoxia | 3 | 2015 | 956 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 80 | 0.130 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 140 | 0.130 |
Why?
| | Ethanol | 2 | 1999 | 534 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 84 | 0.130 |
Why?
| | Critical Care | 1 | 2000 | 472 | 0.130 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 1791 | 0.130 |
Why?
| | Carbonates | 1 | 1995 | 7 | 0.130 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 150 | 0.130 |
Why?
| | Menstruation | 2 | 1986 | 35 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 787 | 0.130 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 2 | 0.120 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 206 | 0.120 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 99 | 0.120 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 398 | 0.120 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 40 | 0.120 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 42 | 0.120 |
Why?
| | Interleukin-10 | 1 | 1997 | 293 | 0.120 |
Why?
| | Vinblastine | 6 | 1997 | 63 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 409 | 0.120 |
Why?
| | Case-Control Studies | 2 | 2019 | 3003 | 0.120 |
Why?
| | Carbon Dioxide | 2 | 1995 | 218 | 0.120 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 26 | 0.120 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 68 | 0.120 |
Why?
| | Oligonucleotides | 1 | 1995 | 137 | 0.120 |
Why?
| | Liver | 2 | 2000 | 1633 | 0.120 |
Why?
| | Vasoconstriction | 3 | 1988 | 177 | 0.120 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 43 | 0.120 |
Why?
| | Liposomes | 3 | 1997 | 146 | 0.120 |
Why?
| | Reperfusion | 2 | 1992 | 35 | 0.120 |
Why?
| | Triazoles | 2 | 2000 | 125 | 0.110 |
Why?
| | Hemolysis | 2 | 1993 | 143 | 0.110 |
Why?
| | Perioperative Care | 1 | 2015 | 126 | 0.110 |
Why?
| | Serum Albumin | 3 | 1994 | 137 | 0.110 |
Why?
| | Insufflation | 1 | 2013 | 9 | 0.110 |
Why?
| | Granulocytes | 3 | 1982 | 75 | 0.110 |
Why?
| | Oligopeptides | 2 | 1992 | 234 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2537 | 0.110 |
Why?
| | Deferoxamine | 2 | 1990 | 17 | 0.110 |
Why?
| | Smoke | 2 | 2007 | 123 | 0.110 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1736 | 0.110 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2783 | 0.110 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 89 | 0.100 |
Why?
| | Pleural Effusion | 4 | 1992 | 46 | 0.100 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 176 | 0.100 |
Why?
| | Serpins | 1 | 1992 | 24 | 0.100 |
Why?
| | Microscopy, Electron | 6 | 2000 | 408 | 0.100 |
Why?
| | Glucose Oxidase | 3 | 1987 | 18 | 0.100 |
Why?
| | Middle Aged | 10 | 2019 | 26605 | 0.100 |
Why?
| | Adult | 22 | 2019 | 30375 | 0.100 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 18 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2015 | 268 | 0.100 |
Why?
| | Opsonin Proteins | 7 | 1988 | 25 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2014 | 316 | 0.100 |
Why?
| | Brain | 3 | 1992 | 2355 | 0.100 |
Why?
| | Respiration | 3 | 2001 | 180 | 0.100 |
Why?
| | Inhalation | 1 | 2011 | 26 | 0.090 |
Why?
| | Melanocytes | 1 | 1991 | 55 | 0.090 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 489 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 1992 | 221 | 0.090 |
Why?
| | Escherichia coli | 3 | 1988 | 723 | 0.090 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 165 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1558 | 0.090 |
Why?
| | Oxidoreductases | 1 | 1991 | 89 | 0.090 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 52 | 0.090 |
Why?
| | Muramidase | 3 | 1988 | 72 | 0.090 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 898 | 0.090 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 86 | 0.090 |
Why?
| | Fibroblasts | 3 | 1991 | 834 | 0.090 |
Why?
| | Cell Movement | 5 | 1996 | 863 | 0.090 |
Why?
| | Xenon Isotopes | 2 | 2007 | 3 | 0.090 |
Why?
| | Shock | 1 | 1991 | 83 | 0.090 |
Why?
| | Diterpenes | 3 | 1975 | 31 | 0.090 |
Why?
| | Base Sequence | 5 | 1999 | 2114 | 0.090 |
Why?
| | Riboflavin | 1 | 1990 | 7 | 0.090 |
Why?
| | Paraquat | 1 | 1990 | 14 | 0.090 |
Why?
| | Keratinocytes | 1 | 1991 | 215 | 0.090 |
Why?
| | Glycoconjugates | 1 | 1990 | 7 | 0.090 |
Why?
| | Exercise | 1 | 2000 | 1642 | 0.080 |
Why?
| | Blood Cells | 1 | 1990 | 38 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 1990 | 56 | 0.080 |
Why?
| | Complement C2 | 3 | 1979 | 6 | 0.080 |
Why?
| | RNA | 1 | 1995 | 807 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 739 | 0.080 |
Why?
| | Mice | 5 | 2016 | 14841 | 0.080 |
Why?
| | Factor VII | 1 | 1989 | 24 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 36 | 0.080 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.080 |
Why?
| | Substrate Specificity | 3 | 1996 | 350 | 0.080 |
Why?
| | Metals | 1 | 1990 | 105 | 0.080 |
Why?
| | Intestines | 1 | 1992 | 325 | 0.080 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 142 | 0.080 |
Why?
| | Time Factors | 10 | 2000 | 6077 | 0.080 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 11 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2005 | 2550 | 0.080 |
Why?
| | Blood Pressure | 6 | 1995 | 1531 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 35 | 0.080 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.080 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 50 | 0.080 |
Why?
| | Superantigens | 1 | 1988 | 69 | 0.080 |
Why?
| | Antigens | 2 | 1989 | 317 | 0.080 |
Why?
| | Enterotoxins | 1 | 1988 | 88 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 1981 | 0.080 |
Why?
| | Proteins | 5 | 1997 | 906 | 0.080 |
Why?
| | Thromboxane B2 | 2 | 1988 | 26 | 0.080 |
Why?
| | Nitroarginine | 2 | 1999 | 47 | 0.080 |
Why?
| | Epithelial Cells | 2 | 2007 | 946 | 0.080 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 605 | 0.070 |
Why?
| | Nitroprusside | 2 | 1999 | 64 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 1988 | 103 | 0.070 |
Why?
| | Inhalation Exposure | 1 | 2008 | 96 | 0.070 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 6 | 0.070 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 31 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 1999 | 1846 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 82 | 0.070 |
Why?
| | Image Enhancement | 1 | 2008 | 158 | 0.070 |
Why?
| | Alcoholism | 1 | 2014 | 710 | 0.070 |
Why?
| | Phospholipids | 2 | 2000 | 194 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2000 | 75 | 0.070 |
Why?
| | Nylons | 3 | 1984 | 18 | 0.070 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 36 | 0.070 |
Why?
| | Complement Activation | 3 | 1995 | 337 | 0.070 |
Why?
| | Zymosan | 5 | 1990 | 64 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3039 | 0.070 |
Why?
| | Disease | 2 | 2017 | 85 | 0.070 |
Why?
| | Thromboxane A2 | 2 | 1983 | 11 | 0.070 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 62 | 0.070 |
Why?
| | Arginine | 2 | 1998 | 236 | 0.070 |
Why?
| | DNA, Complementary | 2 | 1999 | 255 | 0.070 |
Why?
| | Cell Division | 2 | 1985 | 754 | 0.070 |
Why?
| | Menstrual Cycle | 1 | 1986 | 108 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 990 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 347 | 0.060 |
Why?
| | Cytochrome c Group | 3 | 1994 | 35 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 353 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 51 | 0.060 |
Why?
| | Glycoproteins | 1 | 1987 | 304 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1999 | 522 | 0.060 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.060 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 340 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 219 | 0.060 |
Why?
| | Models, Biological | 4 | 2011 | 1611 | 0.060 |
Why?
| | Drug Carriers | 2 | 1997 | 112 | 0.060 |
Why?
| | Purines | 3 | 1998 | 158 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 31 | 0.060 |
Why?
| | Isotopes | 3 | 2011 | 27 | 0.060 |
Why?
| | Peroxidases | 2 | 1991 | 25 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 253 | 0.060 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 73 | 0.060 |
Why?
| | Aspirin | 2 | 1984 | 324 | 0.060 |
Why?
| | Mesocricetus | 2 | 1995 | 29 | 0.060 |
Why?
| | Kidney Diseases | 1 | 1987 | 349 | 0.060 |
Why?
| | Genetic Therapy | 1 | 2005 | 256 | 0.060 |
Why?
| | Mannitol | 4 | 1991 | 32 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2003 | 83 | 0.050 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.050 |
Why?
| | Cricetinae | 2 | 1995 | 252 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2003 | 19 | 0.050 |
Why?
| | Lidocaine | 3 | 1987 | 40 | 0.050 |
Why?
| | Vasodilator Agents | 2 | 1999 | 302 | 0.050 |
Why?
| | Osmolar Concentration | 3 | 1994 | 169 | 0.050 |
Why?
| | Methylprednisolone | 1 | 1983 | 80 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 694 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 1998 | 3498 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 295 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 310 | 0.050 |
Why?
| | Tetracaine | 2 | 1979 | 3 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 7 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 8 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 86 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 40 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 18 | 0.050 |
Why?
| | Pyelonephritis | 1 | 1982 | 7 | 0.050 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 4 | 0.050 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 113 | 0.050 |
Why?
| | Signal Transduction | 1 | 1995 | 4501 | 0.050 |
Why?
| | Chromatography, Gas | 3 | 1988 | 27 | 0.050 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 6 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 507 | 0.050 |
Why?
| | Prospective Studies | 3 | 2019 | 6195 | 0.050 |
Why?
| | Environmental Pollution | 1 | 2001 | 17 | 0.050 |
Why?
| | Volatilization | 1 | 2001 | 49 | 0.050 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 113 | 0.050 |
Why?
| | DNA, Superhelical | 1 | 1981 | 11 | 0.050 |
Why?
| | Lasers, Excimer | 1 | 2001 | 21 | 0.050 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 8 | 0.050 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 12 | 0.050 |
Why?
| | Glucose | 8 | 1980 | 899 | 0.050 |
Why?
| | Mycoses | 1 | 1981 | 66 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 1690 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 192 | 0.040 |
Why?
| | Urea | 3 | 1990 | 66 | 0.040 |
Why?
| | Organ Preservation | 2 | 1991 | 64 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 33 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2000 | 28 | 0.040 |
Why?
| | Hot Temperature | 3 | 1994 | 301 | 0.040 |
Why?
| | DNA Primers | 2 | 1999 | 508 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2003 | 719 | 0.040 |
Why?
| | Azepines | 1 | 2000 | 69 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 85 | 0.040 |
Why?
| | Ethylenes | 1 | 1979 | 11 | 0.040 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.040 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.040 |
Why?
| | Glutathione Reductase | 2 | 1990 | 21 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 111 | 0.040 |
Why?
| | Chemical Phenomena | 2 | 1995 | 80 | 0.040 |
Why?
| | Coronary Circulation | 3 | 1991 | 134 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 374 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 36 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 368 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 128 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 41 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 161 | 0.040 |
Why?
| | Myocardial Infarction | 3 | 1991 | 932 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 486 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 78 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 43 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 89 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 349 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 9 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 318 | 0.040 |
Why?
| | Coculture Techniques | 1 | 1999 | 198 | 0.040 |
Why?
| | Gerbillinae | 2 | 1990 | 61 | 0.040 |
Why?
| | Hyperoxia | 1 | 1999 | 99 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 78 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 1979 | 81 | 0.040 |
Why?
| | Acetylcholine | 1 | 1999 | 166 | 0.040 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 99 | 0.040 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 72 | 0.040 |
Why?
| | Aged | 5 | 2019 | 18969 | 0.040 |
Why?
| | Levamisole | 1 | 1977 | 19 | 0.040 |
Why?
| | HIV Infections | 1 | 1992 | 2453 | 0.040 |
Why?
| | Oleic Acid | 1 | 1997 | 30 | 0.040 |
Why?
| | Cloning, Organism | 1 | 1997 | 6 | 0.040 |
Why?
| | Linoleic Acid | 1 | 1997 | 37 | 0.040 |
Why?
| | Muscle Contraction | 2 | 1990 | 388 | 0.040 |
Why?
| | Phospholipases A2 | 1 | 1997 | 73 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2001 | 479 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 465 | 0.040 |
Why?
| | Methane | 3 | 1983 | 43 | 0.040 |
Why?
| | Complement System Proteins | 2 | 1977 | 281 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 157 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1257 | 0.030 |
Why?
| | Electron Transport | 2 | 1995 | 108 | 0.030 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 23 | 0.030 |
Why?
| | NADP | 2 | 1988 | 42 | 0.030 |
Why?
| | Absorption | 1 | 1997 | 52 | 0.030 |
Why?
| | Injury Severity Score | 1 | 1999 | 472 | 0.030 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 7 | 0.030 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.030 |
Why?
| | Isoelectric Point | 1 | 1996 | 22 | 0.030 |
Why?
| | Immunoassay | 1 | 1997 | 95 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 173 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1080 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 15 | 0.030 |
Why?
| | Adenine | 2 | 1997 | 218 | 0.030 |
Why?
| | Sepharose | 1 | 1996 | 31 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 1695 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 73 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 37 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 714 | 0.030 |
Why?
| | Sodium Chloride | 2 | 1990 | 133 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 204 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 17800 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 37 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 6 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 22 | 0.030 |
Why?
| | Injections | 1 | 1996 | 160 | 0.030 |
Why?
| | Cell Separation | 1 | 1997 | 290 | 0.030 |
Why?
| | United States | 1 | 2011 | 12137 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 42 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 259 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 8 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 52 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 118 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 283 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 441 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 101 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 101 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 27 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 201 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 46 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 16 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 6 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 2 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 362 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2349 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 30 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 77 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 36 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 41 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 5 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 286 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 74 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 60 | 0.030 |
Why?
| | Anions | 3 | 1995 | 29 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 771 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 331 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 6 | 0.030 |
Why?
| | Methods | 2 | 1984 | 57 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 82 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 77 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 214 | 0.030 |
Why?
| | Diptera | 1 | 1993 | 27 | 0.030 |
Why?
| | Stomach | 1 | 1994 | 102 | 0.030 |
Why?
| | Haploidy | 1 | 1993 | 21 | 0.030 |
Why?
| | Genes | 1 | 1993 | 223 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 11 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 239 | 0.030 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 152 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1993 | 323 | 0.030 |
Why?
| | Hemoglobins | 1 | 1995 | 308 | 0.030 |
Why?
| | Epoprostenol | 2 | 1991 | 133 | 0.030 |
Why?
| | Survival Rate | 1 | 1997 | 1638 | 0.030 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 669 | 0.030 |
Why?
| | Platelet Count | 2 | 1984 | 79 | 0.030 |
Why?
| | Drosophila | 1 | 1993 | 133 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2764 | 0.030 |
Why?
| | Chromium | 1 | 1992 | 12 | 0.030 |
Why?
| | NF-kappa B | 1 | 1996 | 636 | 0.020 |
Why?
| | Disease Progression | 1 | 1999 | 2371 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1992 | 198 | 0.020 |
Why?
| | Indoles | 1 | 1994 | 300 | 0.020 |
Why?
| | Gene Expression | 2 | 1995 | 1417 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1996 | 1656 | 0.020 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.020 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.020 |
Why?
| | Elapid Venoms | 1 | 1991 | 14 | 0.020 |
Why?
| | Mechlorethamine | 2 | 1982 | 63 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 766 | 0.020 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.020 |
Why?
| | Pentetic Acid | 1 | 1991 | 12 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1468 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 46 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 6 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 57 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 246 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 212 | 0.020 |
Why?
| | Azides | 1 | 1990 | 46 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 28 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 47 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 246 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 136 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 140 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 868 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 114 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 144 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 133 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 62 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1014 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 674 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1218 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 289 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 3315 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 30 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 295 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 47 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 112 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 47 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 564 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 5 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 9 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 413 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 4392 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 10 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 266 | 0.020 |
Why?
| | Helium | 1 | 2007 | 6 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 13 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 27 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 35 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 265 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 380 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 45 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 18 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 723 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 18 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 106 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 188 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 315 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 123 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1988 | 421 | 0.020 |
Why?
| | Brain Ischemia | 1 | 1990 | 297 | 0.020 |
Why?
| | Drug Synergism | 1 | 1986 | 315 | 0.020 |
Why?
| | Carboxypeptidases | 1 | 1985 | 12 | 0.020 |
Why?
| | Carotid Arteries | 1 | 1987 | 180 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 1985 | 26 | 0.020 |
Why?
| | Surface Properties | 1 | 2007 | 385 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 428 | 0.020 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 98 | 0.020 |
Why?
| | Sheep | 2 | 1988 | 761 | 0.020 |
Why?
| | Cell Communication | 1 | 1987 | 277 | 0.020 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.020 |
Why?
| | Granuloma | 1 | 1985 | 82 | 0.020 |
Why?
| | Lipid Peroxides | 1 | 1985 | 9 | 0.020 |
Why?
| | Blood Glucose | 4 | 1983 | 1827 | 0.020 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 29 | 0.020 |
Why?
| | Hemodynamics | 4 | 1991 | 1015 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1143 | 0.010 |
Why?
| | Rheology | 1 | 1985 | 86 | 0.010 |
Why?
| | Mucous Membrane | 1 | 1985 | 108 | 0.010 |
Why?
| | Cough | 1 | 1985 | 107 | 0.010 |
Why?
| | Pleurisy | 1 | 1983 | 6 | 0.010 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 725 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 459 | 0.010 |
Why?
| | Singlet Oxygen | 1 | 1984 | 19 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 121 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 137 | 0.010 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 24 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 328 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 18 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 269 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1624 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 231 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 247 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 241 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 397 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 163 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 321 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1144 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 287 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 735 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 13 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 24 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 60 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 203 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 386 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 83 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 55 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 14 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 33 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 61 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 23 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 116 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 188 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 445 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 4 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 12 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 9 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 22 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 20 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 38 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 22 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 53 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 14 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 20 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 138 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 7 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 79 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 250 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 196 | 0.010 |
Why?
| | Cell Membrane | 2 | 1978 | 670 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1331 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 224 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 541 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 9 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 2 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 16 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 54 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 34 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 4 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 330 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 81 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 61 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 90 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 67 | 0.010 |
Why?
| | Protons | 1 | 1995 | 73 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 314 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 93 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 119 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 74 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 36 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 24 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 485 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 72 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 69 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 241 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 233 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 591 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 75 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 144 | 0.010 |
Why?
| | Blood | 1 | 1991 | 94 | 0.010 |
Why?
| | Insulin | 1 | 1980 | 2080 | 0.010 |
Why?
| | Cold Temperature | 1 | 1991 | 125 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 134 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 19 | 0.010 |
Why?
| | Child | 2 | 1979 | 18400 | 0.010 |
Why?
| | Half-Life | 1 | 1989 | 141 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1311 | 0.010 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 70 | 0.000 |
Why?
| | Phenotype | 1 | 1976 | 2784 | 0.000 |
Why?
| | Microspheres | 1 | 1989 | 123 | 0.000 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.000 |
Why?
| | Fluoresceins | 1 | 1988 | 46 | 0.000 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 37 | 0.000 |
Why?
| | Thiocyanates | 1 | 1988 | 29 | 0.000 |
Why?
| | Complement C5 | 1 | 1988 | 73 | 0.000 |
Why?
| | Coronary Vessels | 1 | 1990 | 234 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 5 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1471 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 228 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 225 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 298 | 0.000 |
Why?
| | Swine | 1 | 1988 | 687 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 257 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 513 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 18 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 6 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 17 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 13 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 27 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 66 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 66 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 81 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 70 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 115 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|